Natalizumab in Combination With Glatiramer Acetate (GA) in Patients With Relapsing-Remitting Multiple Sclerosis
Status:
Completed
Trial end date:
2004-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if natalizumab in combination with Glatiramer
Acetate (GA) is safe and effective in delaying progression of individuals diagnosed with
relapsing-remitting Multiple Sclerosis (MS).